Home Other Building Blocks 2-(3-Pyridyl)benzimidazole

2-(3-Pyridyl)benzimidazole

CAS No.:
1137-67-3
Catalog Number:
AG0009DY
Molecular Formula:
C12H9N3
Molecular Weight:
195.2200
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95+%
1 week
United States
$66
- +
5g
95+%
1 week
United States
$144
- +
Product Description
Catalog Number:
AG0009DY
Chemical Name:
2-(3-Pyridyl)benzimidazole
CAS Number:
1137-67-3
Molecular Formula:
C12H9N3
Molecular Weight:
195.2200
MDL Number:
MFCD01632544
IUPAC Name:
2-pyridin-3-yl-1H-benzimidazole
InChI:
InChI=1S/C12H9N3/c1-2-6-11-10(5-1)14-12(15-11)9-4-3-7-13-8-9/h1-8H,(H,14,15)
InChI Key:
BOUOQESVDURNSB-UHFFFAOYSA-N
SMILES:
c1ccc(cn1)c1nc2c([nH]1)cccc2
NSC Number:
62610
Properties
Complexity:
219  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
195.08g/mol
Formal Charge:
0
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
195.225g/mol
Monoisotopic Mass:
195.08g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
41.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2  
Literature
Title Journal
Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation. Journal of medicinal chemistry 20120412
Selective fluorometric detection of pyrophosphate and stringent alarmone with copper(II)-2,6-bis(2-benzimidazolyl)pyridine complex. Biosensors & bioelectronics 20111215
Optimizing sensitization processes in dinuclear luminescent lanthanide oligomers: selection of rigid aromatic spacers. Journal of the American Chemical Society 20111012
Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones. Scientia pharmaceutica 20110101
Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. Bioorganic & medicinal chemistry letters 20100715
2-(3-Pyridinio)benzimidazolium penta-chloridoanti-monate(III) monohydrate. Acta crystallographica. Section E, Structure reports online 20090601
Poly[[2-(3-pyridinio)-1H,3H-benzimidazolium] [μ(4)-oxido-di-μ(3)-oxido-tetra-μ(2)-oxido-hexa-oxidotetra-molybdenum(VI)]]. Acta crystallographica. Section E, Structure reports online 20090501
catena-Poly[[bis-[μ-2-(3-pyrid-yl)-1H-benzimidazole]-κN:N;κN:N-disilver(I)]-μ-2,5-dicarboxy-benzene-1,4-dicarboxyl-ato-κO:O]. Acta crystallographica. Section E, Structure reports online 20080301
Influence of lipophilia and of the vehicle used in the transdermal absorption of novel benzimidazole compounds with possible anti-HIV activity. Pharmaceutical development and technology 20080101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Metal-mediated inhibition of Escherichia coli methionine aminopeptidase: structure-activity relationships and development of a novel scoring function for metal-ligand interactions. Journal of medicinal chemistry 20060126
SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes. Journal of the American Chemical Society 20040303
Properties